Serum Evaluation of Helicobacter pylori in Patients with Multiple Sclerosis

被引:0
作者
Meshkat, Mojtaba [1 ]
Behjati, Yeganeh [2 ]
Bakhshi, Mansooreh [3 ]
Meshkat, Zahra [4 ]
Mehr, Mina Yazdan [3 ]
Boostani, Reza [5 ]
Saeidi, Morteza [5 ]
Khoshakhlagh, Mahdieh [6 ]
Chechaklou, Amin Hooshyar [4 ]
Najjari, Mahya [3 ]
Abolbashari, Samaneh [4 ]
Gholoobi, Aida [7 ,8 ]
机构
[1] Islamic Azad Univ, Fac Med, Dept Community Med, Mashhad Med Sci, Mashhad, Razavi Khorasan, Iran
[2] Mashhad Univ Med Sci, Student Res Comm, Mashhad, Razavi Khorasan, Iran
[3] Mashhad Univ Med Sci, Dept Microbiol & Virol, Fac Med, Mashhad, Razavi Khorasan, Iran
[4] Mashhad Univ Med Sci, Antimicrobial Resistance Res Ctr, Mashhad, Razavi Khorasan, Iran
[5] Mashhad Univ Med Sci, Ghaem Hosp, Dept Neurol, Mashhad, Razavi Khorasan, Iran
[6] Mashhad Univ Med Sci, Dept Biochem, Fac Med, Mashhad, Razavi Khorasan, Iran
[7] Mashhad Univ Med Sci, Metab Syndrome Res Ctr, Mashhad, Razavi Khorasan, Iran
[8] Mashhad Univ Med Sci, Med Genet Res Ctr, Mashhad, Razavi Khorasan, Iran
关键词
Helicobacter pylori; Multiple Sclerosis; Serology; IgG Antibodies; INFECTION; RISK;
D O I
10.5812/ans-133607
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Multiple sclerosis (MS) is an autoimmune inflammatory disorder of the central nervous system of unknown etiology, which is believed to be caused by immune dysregulation triggered by genetic and environmental factors, leading to demyelination and axonal loss. Researchers consider infectious agents, like Helicobacter pylori, as these environmental factors. H. pylori can permanently infect someone's stomach and cause an acute or chronic inflammatory response, in which inflammatory mediators affect the brain and cause a pathologic disease. Methods: In this cross-sectional study, 38 patients with multiple sclerosis who were referred to the Neurology Clinic of Ghaem Hospital were included, and their serum samples were analyzed for IgM, IgA, and IgG antibodies against H. pylori by using enzyme-linkedimmunosorbentassay (ELISA). Resultswerecomparedwith the samples of 41 sex- andage-matched controls admitted to other wards of Ghaem Hospital & had no symptoms of MS. In the end, we analyzed the data with SPSS v.20. Results: In this study, 79 patients, including 38 patients with MS disease in the case group and 41 healthy individuals in the control group, were studied. These two groups had no significant differences in demographic characteristics, including age, gender, and occupation. H. pylori seropositivity was significantly higher in patients with MS than in controls (68.4% vs 39%) (P = 0.009). In addition, comparing H. pylori seropositivity in 20 of 30 patients with relapsing-remitting MS versus 6 of 8 patients with progressive MSsuggested a significant difference between these two groups (P = 0.030). Also, H. pylori seropositivityhadnosignificant difference between males and females (39.1% vs 58.9%). Conclusions: The prevalence of H. pylori seropositivity was significantly higher in patients with MS than in control, besides this seems more frequent in a progressive type of MS than in a relapsing-remitting one, suggesting that H. pylori might be a causal factor for developing & progressing MS and this may have an adverse impact on the prognosis and course of the disease.
引用
收藏
页数:7
相关论文
共 32 条
  • [1] Aboud RS, 2018, Curr Res Microbiol Biotechnol, V6, P1536
  • [2] Ahadiat S.-A., 2022, Neurol. Lett, V1, P28, DOI [10.52547/nl.1.1.28, DOI 10.52547/NL.1.1.28]
  • [3] Alvarez-Arellano Lourdes, 2014, World J Gastrointest Pathophysiol, V5, P400, DOI 10.4291/wjgp.v5.i4.400
  • [4] Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis
    Azami, Milad
    YektaKooshali, Mohammad Hossein
    Shohani, Masoumeh
    Khorshidi, Ali
    Mahmudi, Leily
    [J]. PLOS ONE, 2019, 14 (04):
  • [5] Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis
    Capasso, Nicola
    Nozzolillo, Agostino
    Scalia, Giulia
    Lanzillo, Roberta
    Carotenuto, Antonio
    De Angelis, Marcello
    Petruzzo, Martina
    Sacca, Francesco
    Russo, Cinzia Valeria
    Morra, Vincenzo Brescia
    Moccia, Marcello
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 49
  • [6] Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism
    Duscha, Alexander
    Gisevius, Barbara
    Hirschberg, Sarah
    Yissachar, Nissan
    Stangl, Gabriele, I
    Dawin, Eva
    Bader, Verian
    Haase, Stefanie
    Kaisler, Johannes
    David, Christina
    Schneider, Ruth
    Troisi, Riccardo
    Zent, Daniel
    Hegelmaier, Tobias
    Dokalis, Nikolaos
    Gerstein, Sara
    Del Mare-Roumani, Sara
    Amidror, Sivan
    Staszewski, Ori
    Poschmann, Gereon
    Stuehler, Kai
    Hirche, Frank
    Balogh, Andras
    Kempa, Stefan
    Traeger, Pascal
    Zaiss, Mario M.
    Holm, Jacob Bak
    Massa, Megan G.
    Nielsen, Henrik Bjorn
    Faissner, Andreas
    Lukas, Carsten
    Gatermann, Soeren G.
    Scholz, Markus
    Przuntek, Horst
    Prinz, Marco
    Forslund, Sofia K.
    Winklhofer, Konstanze F.
    Mueller, Dominik N.
    Linker, Ralf A.
    Gold, Ralf
    Haghikia, Aiden
    [J]. CELL, 2020, 180 (06) : 1067 - +
  • [7] Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria
    Eckman, Emily
    Laman, Jon D.
    Fischer, Kael F.
    Lopansri, Bert
    Martins, Tom B.
    Hill, Harry R.
    Kriesel, John D.
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2021, 99 (10): : 1399 - 1411
  • [8] Eshaghi A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22265-2
  • [9] B cells and multiple sclerosis
    Franciotta, Diego
    Salvetti, Marco
    Lolli, Francesco
    Serafini, Barbara
    Aloisi, Francesca
    [J]. LANCET NEUROLOGY, 2008, 7 (09) : 852 - 858
  • [10] An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis
    Garg, Neeta
    Smith, Thomas W.
    [J]. BRAIN AND BEHAVIOR, 2015, 5 (09):